Iatrogenic atrial septal defect closure after transseptal mitral valve interventions: Indications and outcomes

被引:19
作者
Beri, Neil [1 ]
Singh, Gagan D. [1 ]
Smith, Thomas W. [1 ]
Fan, Dali [1 ]
Boyd, Walter D. [2 ]
Rogers, Jason H. [1 ]
机构
[1] Univ Calif Davis, Div Cardiovasc Med, Med Ctr, 4860 Y St,Suite 2820, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Med Ctr, Div Cardiothorac Surg, Sacramento, CA 95817 USA
关键词
iASD; iatrogenic atrial septal defect; Mitraclip; mitral valve; transcatheter closure; transseptal puncture; REPAIR; PUNCTURE; ABLATION;
D O I
10.1002/ccd.28294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Review indications and outcomes for transcatheter iatrogenic atrial septal defect (iASD) closure in patients undergoing MitraClip or transseptal (TS) mitral valve-in-valve/ring (ViV/ViR) procedures. Background Mitral valve transcatheter interventions require large-diameter TS sheaths that can result in iASDs that necessitate post-procedure transcatheter closure. Although the presence of iASD has been well-described, indications for closure and outcomes after TS mitral valve interventions have not been reported. Methods Patients undergoing MitraClip repair and ViV or ViR transcatheter mitral valve replacement (TMVR) from February 14, 2014, to January 16, 2018, were studied retrospectively in this single center study. Results Seventeen patients had iASD closure: 11 MitraClip and 6 TMVR (5 ViV, 1 ViR). Indications for iASD closure included large iASD (n = 7), large left-to-right shunt (n = 9), pulmonary hypertension (n = 8), large right-to-left shunt (n = 1), severe RV dysfunction (n = 2), thin/aneurysmal septum (n = 2), and mobile material on pacemaker leads (n = 2). Closures were performed without complications using Amplatzer septal occluders. At 30 days, 94% of subjects (n = 16) were alive with one patient deceased from unknown causes. There were no myocardial infarctions or strokes. At 12 months, follow-up was available for 14 of 17 patients, and 71% of patients (10/14) were alive. One patient died due to cardiac causes, two from noncardiac causes and one for unknown reasons. There was one myocardial infarction, one intraparenchymal hemorrhage, and no ischemic strokes. Conclusions The most common reasons for iASD closure after TS MV procedures are: large ASD unlikely to spontaneously close, large left-to-right shunt, and pulmonary hypertension. Patients who required iASD closure had low 30-day mortality but higher one-year mortality potentially reflecting a population with substantial comorbidities.
引用
收藏
页码:829 / 836
页数:8
相关论文
共 20 条
[1]   Iatrogenic Atrial Septal Defect [J].
Alkhouli, Mohamad ;
Sarraf, Mohammad ;
Holmes, David R. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (04)
[2]   Iatrogenic atrial septal defect following transseptal cardiac interventions [J].
Alkhouli, Mohamad ;
Sarraf, Mohammad ;
Zack, Chad J. ;
Holmes, David R. ;
Rihal, Charanjit S. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 :142-148
[3]   When to close iatrogenic atrial septal defect after percutaneous edge to edge repair of mitral valve regurgitation [J].
Chandraprakasam, Satish ;
Satpathy, Ruby .
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2016, 17 (06) :421-423
[4]   Transseptal Puncture Through Amplatzer Septal Occluder Device for Catheter Ablation of Atrial Fibrillation: Use of Balloon Dilatation Technique [J].
Chen, Ke ;
Sang, Caihua ;
Dong, Jianzeng ;
Ma, Changsheng .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (10) :1139-1141
[5]   Haemodynamic and functional consequences of the iatrogenic atrial septal defect following Mitraclip therapy [J].
Hart, E. A. ;
Zwart, K. ;
Teske, A. J. ;
Voskuil, M. ;
Stella, P. R. ;
Chamuleau, S. A. J. ;
Kraaijeveld, A. O. .
NETHERLANDS HEART JOURNAL, 2017, 25 (02) :137-142
[6]   Postinterventional iatrogenic atrial septal defect with hemodynamically relevant left-to-right and right-to-left shunt as a complication of successful percutaneous mitral valve repair with the MitraClip [J].
Huntgeburth, Michael ;
Mueller-Ehmsen, Jochen ;
Baldus, Stephan ;
Rudolph, Volker .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) :E3-E5
[7]   Safety and feasibility of transseptal puncture for atrial fibrillation ablation in patients with atrial septal defect closure devices [J].
Li, Xuping ;
Wissner, Erik ;
Kamioka, Masashi ;
Makimoto, Hisaki ;
Rausch, Peter ;
Metzner, Andreas ;
Mathew, Shibu ;
Rillig, Andreas ;
Tilz, Roland Richard ;
Furnkranz, Alexander ;
Chen, Qi ;
Zhang, Qingyong ;
Liu, Qiming ;
Zhou, Shenghua ;
Kuck, Karl-Heinz ;
Ouyang, Feifan .
HEART RHYTHM, 2014, 11 (02) :330-335
[8]   Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of PaO2/FiO2 ratio in guiding post-procedural iASD closure [J].
Losi, Maria-Angela ;
Strisciuglio, Teresa ;
Stabile, Eugenio ;
Castellano, Gaetano ;
de Amicis, Vincenzo ;
Saccenti, Alessandro ;
Maresca, Gennaro ;
Santoro, Ciro ;
Izzo, Raffaele ;
Barbato, Emanuele ;
Esposito, Giovanni ;
Trimarco, Bruno ;
Rapacciuolo, Antonio .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 :85-86
[9]   Transseptal Left Heart Catheterization and the Incidence of Persistent Iatrogenic Atrial Septal Defects [J].
McGinty, Patrick M. ;
Smith, Thomas W. ;
Rogers, Jason H. .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2011, 24 (03) :254-263
[10]  
Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI [10.1016/j.jacc.2014.02.537, 10.1016/j.jtcvs.2014.05.014, 10.1016/j.jacc.2014.02.536]